The Atlas II ICD (implantable cardioverter defibrillator) and Atlas II HF CRT-D (cardiac resynchronization therapy defibrillator) devices are capable of delivering unsurpassed energy, giving added security to patients whose hearts are especially difficult to defibrillate. The devices also feature enhanced telemetry speed for faster communications — up to five times faster than predecessor devices — which results in quicker, more convenient follow-up visits for patients and physicians. The devices include a "patient notifier" that vibrates to alert patients, including those who have difficulty hearing, of critical changes in device function so they know to contact their physicians. In addition to patient notification, speed and energy (42 joules of stored and 36 joules of delivered energy), the Atlas II also features proprietary St. Jude Medical technology designed to help devices meet the needs of patients who require high levels of defibrillation therapy and allow optimizing of sensing parameters that may protect against inappropriate ICD shocks.
If you enjoy this content, please share it with a colleague
Added Security for Difficult-to-Defibrillate Hearts Available
Related Content
Sept. 2, 2024 – Medtronic recently shared long-term results from the global Extravascular Implantable Cardioverter ...
February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...
October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...
August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...
August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...
July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...
March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...
February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...
August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...
August 19, 2022 — According to a release just issued by the U.S. Food and Drug Administration (FDA), Medtronic is ...